Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Bella2017on Oct 20, 2017 5:46pm
170 Views
Post# 26839128

Largest Growing Medical Marijuana Market: Arthritis Suffers

Largest Growing Medical Marijuana Market: Arthritis Suffers"Aphria has plans to use Liberty Health Sciences to dominate the US medical marijuana market, just as it has done in Canada. With the largest market for medical marijuana from a target indication perspective being arthritis sufferers, the company believes if it's dispensaries can be located close to the adult lifestyle communities (i.e., retirement homes) it's going to have a population of arthritis sufferers on-tap. However, it's not just arthritis that's common in an elderly population, other medical problems like glaucoma, cancer, etc. are also prevalent." Read more: https://www.minyanville.com/business-news/markets/articles/cannabis-biotech/10/19/2017/id/61034#ixzz4w5TDCNMt
Bullboard Posts